未登录Monalizumab in combination with cetuximab post platinum and anti-PD-(L)1 in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Updated results from a phase II trial
Fayette, J.; Bauman, J.; Salas, S.; Colevas, D.; Even, C.; Cupissol, D.; Posner, M. R.; Lefebvre, G.; Saada-Bouzid, E.; Bernadach, M.; Seiwert, T.; Pearson, A.; Messouak, S.; Cornen, S. L.; Andre, P.; Rotolo, F.; Boyer-Chammard, A.; Cohen, R. B.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏